相关实验视频

Updated: Jun 6, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

穿透大脑的NLRP3抑制剂:一个万能药的发现?

David Harrison¹

¹NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, United Kingdom.

Journal of medicinal chemistry

|December 2, 2024

概括

研究人员正在开发新的脑透抑制剂,针对NLRP3炎症酶. 这一进步可能会导致神经和心脏代谢疾病的新疗法.

科学领域:

免疫学免疫学免疫学
药用化学医学化学
神经科学是一个神经科学.

背景情况:

NLRP3炎症酶是药物开发的关键目标.
早期的抑制剂由于物理化学性质而面临大脑透的限制.
这限制了它们对中枢神经系统疾病的疗效.

研究的目的:

探索开发穿透大脑的NLRP3炎症酶抑制剂的新型支架.
为了克服前几代抑制剂的局限性.
促进神经退行和心脏代谢疾病的新疗法策略.

主要方法:

发现了一种新型的化二基架.
优化药物化学,以改善大脑透.
新型抑制剂的临床前评估 (细节未提供摘要).

主要成果:

对NLRP3炎症酶抑制剂的新型化学支架的识别.
开发具有潜在增强大脑透性能的化合物.
铺平了下一代治疗方法的道路.

结论:

这种新型的化烯基支架代表了NLRP3炎症酶抑制剂研究的重大进展.
脑透抑制剂对治疗阿尔茨海默氏症,帕金森症,多发性硬化症和心脏代谢障碍等疾病具有前景.
这项研究为神经学及其他领域的药物发现开辟了新的途径.

更多相关视频

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...